| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 11,617,187 | 11,090,375 | 9,818,486 | | Cost of Revenue | 8,016,742 | 7,529,403 | 5,379,114 | | | Gross Profit | 3,600,445 | 3,560,972 | 4,439,372 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 544,035 | 624,251 | 2,013,738 | | Non Recurring |
-
| 33,907 | 93,969 | | Others | 1,000,230 | 1,329,410 | 1,114,294 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,056,180 | 1,573,404 | 1,217,371 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (117,496) | 82,068 | 163,794 | | Earnings Before Interest And Taxes | 1,938,684 | 1,655,472 | 1,381,165 | | Interest Expense | 369,878 | 405,319 | 458,150 | | Income Before Tax | 1,568,806 | 1,250,153 | 923,015 | | Income Tax Expense | 665,859 | 494,099 | 314,743 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 902,947 | 756,054 | 608,272 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 902,947 | 756,054 | 608,272 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $902,947 | $756,054 | $608,272 |
|
1.48% Nasdaq 
Income Statement
